Satisfaction and attitudes toward systemic treatments for psoriasis: A cross-sectional study

In psoriasis patients, satisfaction and patients' attitude toward treatment are heteroge-neous depending on several factors and remain poorly investigated, although the avail-ability of several new targeted therapeutic options. A multicentre cross-sectionalinvestigation was conducted to estimate treatment satisfaction and attitudes (awareness,trust, and therapeutic alliance) in a large population of adult psoriasis patients undergoinga systemic biologic or non-biologic agent for moderate-to-severe plaque-type psoriasis.Patients' satisfaction was measured using the Treatment Satisfaction Questionnaire forMedication II questionnaire and patients' attitudes toward treatment were evaluatedusing a Lickert scale. Results were related to patients' and treatment characteristics andtherapeutic outcomes. The study included 899 psoriasis patients and demonstrated high-treatment satisfaction and positive attitudes toward systemic treatments, with greaterinfluence of the perceived efficacy and the type of treatment. Biologic treatments and, inparticular anti-IL17 agents showed higher results. More efforts in developing tools facili-tating communication and exploring important aspects of patients' view are needed